Suppr超能文献

年龄相关性眼病研究(AREDS)中的国立眼科研究所视觉功能问卷:AREDS报告第10号。

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10.

作者信息

Clemons Traci E, Chew Emily Y, Bressler Susan B, McBee Wendy

机构信息

AREDS Coordinating Center, The EMMES Corporation, 401 N Washington Street, Suite 700, Rockville, MD 20850-1707, USA.

出版信息

Arch Ophthalmol. 2003 Feb;121(2):211-7. doi: 10.1001/archopht.121.2.211.

Abstract

OBJECTIVES

To describe the vision-targeted, health-related quality of life, measured with the National Eye Institute Visual Function Questionnaire (NEI-VFQ), in patients with age-related macular degeneration, cataract, or reduced visual acuity; to determine the relationship between the NEI-VFQ subscale scores and clinical measures of visual function; and to assess the internal consistency and reliability of the NEI-VFQ subscales.

DESIGN

The 39-item NEI-VFQ was administered at the 5-year clinic visit to 4077 Age-Related Eye Disease Study participants.

RESULTS

The subscales of the NEI-VFQ had moderate to high internal consistency (Cronbach's alpha = 0.58-0.91). The NEI-VFQ scores for participants with advanced age-related macular degeneration in 1 or both eyes, severe nuclear opacity, reduced visual acuity, or cataract surgery generally were lower than scores for disease-free participants (P<.001).

CONCLUSION

These findings support the use of the NEI-VFQ as a measure of vision-targeted, health-related quality of life among patients with age-related macular degeneration, cataract, or reduced visual acuity.

摘要

目的

使用美国国立眼科研究所视觉功能问卷(NEI-VFQ)描述年龄相关性黄斑变性、白内障或视力下降患者以视力为导向的健康相关生活质量;确定NEI-VFQ分量表得分与视觉功能临床指标之间的关系;并评估NEI-VFQ分量表的内部一致性和可靠性。

设计

在为期5年的门诊随访中,对4077名年龄相关性眼病研究参与者进行了39项NEI-VFQ问卷调查。

结果

NEI-VFQ的分量表具有中度到高度的内部一致性(克朗巴赫α系数=0.58-0.91)。一只或两只眼睛患有晚期年龄相关性黄斑变性、严重核性混浊、视力下降或接受过白内障手术的参与者的NEI-VFQ得分通常低于无疾病参与者的得分(P<0.001)。

结论

这些发现支持将NEI-VFQ用作年龄相关性黄斑变性、白内障或视力下降患者以视力为导向的健康相关生活质量的衡量指标。

相似文献

5
Development of the 25-item National Eye Institute Visual Function Questionnaire.
Arch Ophthalmol. 2001 Jul;119(7):1050-8. doi: 10.1001/archopht.119.7.1050.
9
Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):712-7. doi: 10.1167/iovs.09-3766. Epub 2009 Sep 24.

引用本文的文献

1
Association of Behavioral Factors with Activation in Patients with Age-Related Macular Degeneration or Diabetic Retinopathy.
Clin Ophthalmol. 2025 Aug 30;19:3059-3069. doi: 10.2147/OPTH.S542352. eCollection 2025.
2
Antioxidants in Age-Related Macular Degeneration: Lights and Shadows.
Antioxidants (Basel). 2025 Jan 27;14(2):152. doi: 10.3390/antiox14020152.
4
One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration.
Int J Ophthalmol. 2023 Sep 18;16(9):1496-1502. doi: 10.18240/ijo.2023.09.17. eCollection 2023.
5
The effects of loading ranibizumab on vision-related quality of life in the treatment of low-risk neovascular age-related macular degeneration.
Ther Adv Ophthalmol. 2022 Jul 18;14:25158414221108021. doi: 10.1177/25158414221108021. eCollection 2022 Jan-Dec.
8
Comparison of Quality of Life Questionnaires in Patients with Low Vision.
Turk J Ophthalmol. 2021 Apr 29;51(2):83-88. doi: 10.4274/tjo.galenos.2020.99975.
9
Impact of Visual Field Loss on Vision-Specific Quality of Life in African Americans: The African American Eye Disease Study.
Am J Ophthalmol. 2021 Sep;229:52-62. doi: 10.1016/j.ajo.2021.02.008. Epub 2021 Feb 8.
10
Visual Function in Pentosan Polysulfate Sodium Maculopathy.
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):33. doi: 10.1167/iovs.61.13.33.

本文引用的文献

4
Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.
Ophthalmology. 2001 Oct;108(10):1893-900; discussion 1900-1. doi: 10.1016/s0161-6420(01)00754-0.
5
Visual functioning and general health status in patients with uveitis.
Arch Ophthalmol. 2001 Jun;119(6):841-9. doi: 10.1001/archopht.119.6.841.
7
The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4.
Am J Ophthalmol. 2001 Feb;131(2):167-75. doi: 10.1016/s0002-9394(00)00732-7.
9
Vision rehabilitation for age-related macular degeneration.
Int Ophthalmol Clin. 1999 Fall;39(4):143-62. doi: 10.1097/00004397-199903940-00010.
10
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.
Control Clin Trials. 1999 Dec;20(6):573-600. doi: 10.1016/s0197-2456(99)00031-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验